NEW YORK (Reuters Health) – Specialists at McGill University in Montreal have developed a fertility preservation protocol of immature oocyte retrieval, in vitro maturation, vitrification of the mature…
NEW YORK (Reuters Health) – Intramuscular implantation of autologous bone marrow mononuclear cells is associated with long-term improvements in limb ischemia and may prevent or at least delay…
Dr. Ron Adelman, MD, MPH, FACS at the Yale Eye Center reviews the results of a large study by the National Eye Institute (AREDS) that proposed an effective…
The non-steroidal, anti-inflammatory drugs celecoxib and naproxen sodium do not improve cognitive function, ADAPT trial data indicate. From our partners at VerusMed: VerusMed.com Sponsored by The Doctor’s Channel
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
In this podcast, hosts Drs. Rahul and Rohit Gosain, and Jame Abraham, MD, Cleveland Clinic, highlight findings from the EMBER-3 study comparing imlunestrant alone versus imlunestrant combined with…
Richard Gale, MBChB, PhD, professor of ophthalmology, Hull York Medical School, UK, presents long-term real-world outcomes of intravitreal aflibercept 8 mg in patients with diabetic macular edema. Over…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
Profiling the metabolites produced by cells in Richter transformation could help researchers develop new targeted therapies in the future. Dr. Prajish Iyer from City of Hope National Comprehensive…
Fatima Tuz Zahra, MD, a hematology/oncology fellow at Moffitt Cancer Center, University of South Florida, Tampa, presented real-world data from a retrospective study evaluating the effectiveness of oral…
